Literature DB >> 3526530

Fungal infections in patients with AIDS and AIDS-related complex.

K Holmberg, R D Meyer.   

Abstract

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Americas; Bacterial And Fungal Diseases; Developed Countries; Developing Countries; Diseases; Drugs; Examinations And Diagnoses; Hiv Infections; Infections; Laboratory Examinations And Diagnoses; North America; Northern America; Physical Examinations And Diagnoses; Treatment; United States; Viral Diseases

Mesh：

Year:  1986        PMID： 3526530     DOI： 10.3109/00365548609032326

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


× No keyword cloud information.
  34 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 2.  Fluconazole in the treatment of fungal infections associated with AIDS.

Authors:  S De Wit; N Clumeck
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

3.  Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.

Authors:  Kaaren G Vargas; Sophie Joly
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Effects of amphetamine on development of oral candidiasis in rats.

Authors:  M Freire-Garabal; M J Núñez; J Balboa; A Rodríguez-Cobo; J M López-Paz; M Rey-Méndez; J A Suárez-Quintanilla; J C Millán; J M Mayán
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 5.  Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature.

Authors:  J N Cox; F di Dió; G P Pizzolato; R Lerch; N Pochon
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers.

Authors:  A Lupetti; G Guzzi; A Paladini; K Swart; M Campa; S Senesi
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

8.  In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid.

Authors:  V Joly; R Farinotti; L Saint-Julien; M Chéron; C Carbon; P Yeni
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects.

Authors:  F De Bernardis; M Boccanera; L Rainaldi; C E Guerra; I Quinti; A Cassone
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

10.  Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line.

Authors:  T G Sieck; M A Moors; H R Buckley; K J Blank
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.